Communiqués Burning Rock Biotech Limited

Actions

BNR

US12233L2060

Equipement, fournitures et distribution médicale

Temps Différé Nasdaq 17:13:36 14/08/2026			Varia. 5j.	Varia. 1 janv.
9,170 ^USD	-1,29 %		+4,09 %	-54,49 %

20/07	Burning Rock Biotech Limited et Myriad Genetics annoncent un partenariat mondial de licence technologique stratégique pour étendre les tests HRD à l'international	CI
02/07	Burning Rock Biotech : un dirigeant acquiert des actions pour un montant de 6 182 172 dollars, selon un document de la SEC	MT

Communiqués

02/07	Burning Rock Announces Founder’s Purchase of Its ADSs	AQ
09/06	Burning Rock Reports First Quarter 2026 Financial Results	AQ
28/04	Burning Rock Publishes 2025 Annual Report on Form 20-F	AQ
02/04	Burning Rock Announces Founder’s Purchase of Its ADSs	AQ
12/03	Burning Rock Biotech : Fourth Quarter 2025 Presentation Slides	PU
12/03	Burning Rock Reports Unaudited Fourth Quarter and Full Year 2025 Financial Results	AQ
26/01	Burning Rock Biotech : Milestone in Precision Oncology! Burning Rock Dx’s Breast Cancer NGS CDx Kit Enters the CMDE Priority Review Channel	PU
06/01	Burning Rock Biotech : Liquid Biopsy Technology Granted U.S. Patent, Accelerating Global Layout in Precision Diagnosis	PU
05/01	Burning Rock Announces Founder’s Purchase of Its ADSs	AQ
23/12	Burning Rock Announces Results of 2025 Annual General Meeting	AQ
18/12	From Accreditation to Excellence: Webinar Highlights on CAP, CLIA, and Quality Systems in Clinical Laboratories	PU
01/12	Burning Rock Announces 2025 Annual General Meeting to be Held on December 23, 2025	AQ
01/12	Burning Rock Biotech : BR - 2025 AGM - Notice of AGM (cfb8ff)	PU
20/11	Burning Rock Reports Third Quarter 2025 Financial Results	AQ
20/11	Burning Rock Biotech : Q3 2025 Presentation Slides	PU
24/09/25	Burning Rock Biotech : OncoGuide™ OncoScreen™ Plus CDx System Now Approved in Japan as a Companion Diagnostic for Capivasertib in Breast Cancer	PU
18/09/25	Burning Rock Biotech : Second Quarter 2025 Financial Results	PU
08/09/25	Burning Rock Reports Second Quarter 2025 Financial Results	AQ
06/06/25	Burning Rock Biotech : First Quarter 2025 Financial Results	PU
06/06/25	Burning Rock Biotech : First Quarter 2025 Presentation Slides	PU
06/06/25	Burning Rock Reports First Quarter 2025 Financial Results	AQ
25/03/25	Burning Rock Biotech : Fourth Quarter 2024 Financial Results	PU
25/03/25	Burning Rock Biotech : Fourth Quarter 2024 Presentation Slides	PU
25/03/25	Burning Rock Reports Unaudited Fourth Quarter and Full Year 2024 Financial Results	AQ
02/01/25	Burning Rock Announces Results of 2024 Annual General Meeting	AQ